Emtricitabine/tdf 72189-0403-03
- Manufacturer
- Direct_rx
- Dosage Form
- Tablet, Film Coated
- Route
- Oral
- Product Type
- Human Prescription Drug
- Marketing Start
- December 5, 2022
- Listing Expires
- December 31, 2026
- Application
- ANDA090513
Need to source Emtricitabine/tdf? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Emtricitabine | 200 mg/1 |
| Tenofovir Disoproxil Fumarate | 300 mg/1 |
Drug Class
Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]
Selected Package
72189-0403-03Selected3 TABLET, FILM COATED in 1 BOTTLE (72189-403-03)